11 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Development of biophotonic device based on flexible light emitting textile dedicated to the monitoring and treatment for dermatologic diseases and carcinoma (PHOS-ISTOS)
Date du début: 1 déc. 2013, Date de fin: 30 nov. 2016,
The therapeutic effect of the photodynamic therapy (PDT) depends on a combination of parameters that include drug dose, drug-light interval, oxygen in cells and light irradiance rate. It also varies according to the wavelength distribution of the light source. Finally, a homogeneous and reproducible illumination during the clinical PDT is determinant in preventing under- or overtreatment. So, the ...
Voir le projet
12
Participants partenaires
TERMINÉ
Roadmap for Research and Innovation in Health Technology (ITECH)
Date du début: 1 sept. 2013, Date de fin: 29 févr. 2016,
Research and innovation in Health Technologies continuously deliver new products, devices and services. The “idea to market” process is complex due to multiple actors, institutional bodies and operators. The ITECH project aims at defining a strategy plan in Health Technologies to contribute to the Horizon 2020 Common EU Strategic Framework for Research and Innovation. The Support Action will gathe ...
Voir le projet
5
Participants partenaires
TERMINÉ
Multicentre Preclinical Animal Research Team (Multi-PART)
Date du début: 1 sept. 2013, Date de fin: 31 août 2015,
Millions of Europeans still suffer the consequences of neurological disease, but the number of new drugs coming to market continues to fall. Reasons for the failure of stroke drug efficacy to translate from animals to clinical trials is probably best studied, but the problem is widespread. The economic and social costs of translational failure are substantial; a new approach to translational medic ...
Voir le projet
12
Participants partenaires
TERMINÉ
Towards the establishment of a permanent European Virtual Institute dedicated to Malaria Research (EVIMalaR) (EVIMalaR)
Date du début: 1 oct. 2009, Date de fin: 31 mars 2015,
This is a proposal from 55 partners from 36 institutes to form a NoE that will seek to integrate European malaria research that is directed towards a better understanding of the basic biology of the parasite, its vector and of the biology of the interactions between the parasite and both its mammalian host and vectors. All the member institutes and researchers have demonstrated both their excellen ...
Voir le projet
40
Participants partenaires
TERMINÉ
Coordination Action in support of the implementation of a Joint Programming Initiative for Combating Neurodegenerative Diseases, in particular Alzheimer’s disease (JUMPAHEAD)
Date du début: 1 sept. 2010, Date de fin: 31 août 2014,
The objective of the Coordination Action JUMPAHEAD is to support the implementation of the pilot Joint Programming Initiative on combating neurodegenerative diseases, in particular Alzheimer’s disease (JPND).Neurodegenerative disorders are incurable and debilitating conditions that result in progressive degeneration or death of nerve cells. Of these, the dementias are responsible for the greatest ...
Voir le projet
13
Participants partenaires
TERMINÉ
European Stroke Research Network (EUSTROKE)
Date du début: 1 mars 2008, Date de fin: 31 août 2013,
The European Stroke Research Network (EUSTROKE) will be a collaborative effort that brings together researchers, government, industry, the non-profit sector and patient group associations. This network will put Europe at the forefront of stroke research through its multi-disciplinary research program, high-quality training for European scientists and clinicians, and national and global partnership ...
Voir le projet
17
Participants partenaires
TERMINÉ
Affording Recovery In Stroke (ARISE)
Date du début: 1 mars 2008, Date de fin: 31 août 2013,
"Stroke poses a massive clinical, social and economic burden, yet we have very limited effective therapies. This inadequacy is in spite of intensive research efforts and numerous failed clinical trials. Leading European stroke researchers and clinicians with a track record of established cooperation will share their complementary expertise, and team up with SME partners with high profile R&D and o ...
Voir le projet
17
Participants partenaires
TERMINÉ
Role of the nuclear receptor Rev-erbalpha in lipid and glucose homeostasis and the transduction of circadian signals into metabolic responses (GLUCOCLOCK)
Date du début: 1 sept. 2009, Date de fin: 31 août 2013,
"The increasing incidence of obesity and type 2 diabetes is becoming a major health problem in the European Community and has a considerable economic and social cost. There is therefore an urgent need to understand the basics of these diseases. Physiological processes are subjected to natural daily fluctuations. Interestingly, daily cycles in insulin secretion and glucose tolerance are lost in pat ...
Voir le projet
1
Participant partenaire
TERMINÉ
Schistosoma Epigenetics - Targets, Regulation, New Drugs (SEtTReND)
Date du début: 1 janv. 2010, Date de fin: 31 déc. 2012,
We propose to develop novel drug leads for the therapy of the major human parasitic disease, schistosomiasis, using a holistic approach that will enable us to progress from the cloned target protein to the lead compound and from epigenetic inhibitors to crucial targets. For this, we have chosen to target the histone modifying enzymes (HME); histone deacetylases (HDAC), histone acetyltransferases ( ...
Voir le projet
9
Participants partenaires
TERMINÉ
Signalling in life cycle stages of malaria parasites (MALSIG)
Date du début: 1 févr. 2009, Date de fin: 31 juil. 2012,
Malaria is a major public health problem in the developing world and is endemic in many regions of India. The development of novel strategies for malaria control requires a better understanding of the biology of malaria parasites. Our project aims at bringing a significant contribution to this field, through dissecting the signalling pathways that regulate essential processes in the life cycle o ...
Voir le projet
18
Participants partenaires
TERMINÉ
"Coordination, rationalisation and integration of antimalarial drug discovery initiatives" (CRIMALDDI)
Date du début: 1 févr. 2009, Date de fin: 30 juin 2011,
"Antimalarial drug discovery and development initiatives globally are fragmented and uncoordinated. We have brought together key organisations including MMV, WHO and AntiMal, an EU-funded FP6 Integrated Project represented by its coordinating institution and a number of academic malaria researchers, to resolve this problem through a logical series of meetings, conferences, workshops and dissemina ...
Voir le projet